Results 121 to 130 of about 875,619 (302)

INTERNATIONAL EDITORIAL ADVISORY BOARD [PDF]

, 2007

openalex   +1 more source

Luspatercept for Transfusion‐Dependent Beta‐Thalassemia: Real‐World Experience in a Large Cohort of Patients From Italy

American Journal of Hematology, EarlyView.
Raffaella Origa, Barbara Gianesin, Antonietta Zappu, Anna Rita Denotti, Mary Ann Di Giorgio, Roberta Sciortino, Irene Motta, Daniele Lello Panzieri, Rosamaria Rosso, Anna Bulla, Martina Culcasi, Anna Maria Pasanisi, Lucia De Franceschi, Rosario Di Maggio, Valeria Maria Pinto, Paola Maria Grazia Sanna, Paolo Ricchi, Giovan Battista Ruffo, Francesca Schieppati, Domenico Roberti, Giovanni Battista Ferrero, Elisa De Michele, Francesco Arcioni, Ilaria Fotzi, Sarah Marktel, Antonella Poloni, Giulia Soverini, Epifania Rita Testa, Giusy Cabiddu, Carmelo Fortugno, Antonia Gigante, Francesca Polese, Davide Rapezzi, Antonella Sau, Gian Luca Forni, Maria Domenica Cappellini, Filomena Longo   +36 more
wiley   +1 more source

Peripheral blood gene expression profiling shows prognostic significance for the course of interstitial lung disease in systemic sclerosis

Arthritis &Rheumatology, Accepted Article.
Objective We used data from the placebo arm of the SENSCIS trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) with and without mycophenolate mofetil (MMF) treatment ...
Shervin Assassi, Christopher P. Denton, Matthias Zwick, Ramona Schmid, Carina Ittrich, Tobias Litzenburger, Sudha Visvanathan   +6 more
wiley   +1 more source

American Journal of Ophthalmology International Editorial Board 1995

, 1995
P Amalric, J. Barraquer, Rubens Belfort, Alan C. Bird, R. Brancato   +4 more
openalex   +1 more source

Efficacy and Safety of ABBV‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial

Arthritis &Rheumatology, Accepted Article.
Objective Despite availability of biologics and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit, Atul Singhal, Alan Kivitz, Edit Drescher, Yoshinori Taniguchi, Rosalía Martínez Pérez, Jaclyn Anderson, Ronilda D'Cunha, Weihan Zhao, Nicholas DeVogel, Julie Parmentier, Romy Christmann, Dilek Arikan, Howard Amital   +13 more
wiley   +1 more source

Qualitative and Quantitative Status and International Visibility of Iranian Journals Indexed in Journal Citation Reports

Iranian Journal of Information Processing & Management, 2016
Objectives: The present study aims to investigate the international status and visibility of Iranian journals which have been indexed in Journal Citation Reports (JCR).
Mohammadamin Erfanmanesh, Fereshteh Nojavan   +1 more
doaj  

International Editorial Board

, 1995
Bradley R. Straatsma, Thomas Aaberg, George B. Bartley, Gary N. Holland, Mark J. Mannis, Jay S. Pepose, J. Bronwyn Bateman, William Denver, Rochester Bourne, Joseph Caprioli, Angeles Los, Atlanta Grossniklaus, Thomas E. Cleveland, Robert Liesegang, Leo Durham, Neil Maguire, Bartly Miller, Los Mondino, Nancy Angeles, Robert Newman, Allen Nussenblatt, Chicago Putterman, A Narsing, Los Rao, Merlyn Angeles, Baltimore Rodrigues, Durham Shields, Iowa Stanley Thompson, Elias City, P Amalric, Rubens Belfort, Alan C. Bird, Francisco Martínez-Castro, Mexico City, Hugh R. Taylor, Stephen M. Drance, Canada Arthur, Sheng Yang Lim, Enrique Malbran, Pran Nath, Gottfried O.H. Naumann, Álvaro Ruiz Rodríguez, Koïchi Shimizu, Hugh R. Taylor, Mark O.M. Tso, Hong Kong   +45 more
openalex   +1 more source

INTERNATIONAL EDITORIAL ADVISORY BOARD [PDF]

, 2009

openalex   +1 more source

Pharmacodynamic Effects of Litifilimab in Lupus in the LILAC Phase II Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines

Arthritis &Rheumatology, Accepted Article.
Objective The pharmacodynamic effects of litifilimab on type I interferon (IFN) response and correlations with clinical outcomes were investigated in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Methods Participants from Part A (SLE) or Part B (CLE with/without SLE) of the randomized phase II LILAC trial who received ...
Richard Furie, Victoria P. Werth, Eric Milliman, Kyle Ferber, Roland Brown, Jad Zoghbi, Nathalie Franchimont, Youmna Lahoud, Catherine Barbey   +8 more
wiley   +1 more source

IOC/IASC/IHO Editorial Board for the International Bathymetric Chart of the Arctic Ocean

, 2000
R Macnab, N Guy
openalex   +1 more source